Re: Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer: The ORIOLE Phase 2 Randomized Clinical Trial

被引：0
|
作者：
Augugliaro, Matteo [1 ]
Pepa, Matteo [1 ]
Marvaso, Giulia [1 ,2 ]
Jereczek-Fossa, Barbara Alicja [1 ,2 ]
机构：
[1] IEO European Inst Oncol IRCCS, Div Radiat Oncol, Via Ripamonti 435, I-20141 Milan, Italy
[2] Univ Milan, Dept Oncol & Hematooncol, Milan, Italy
来源：
EUROPEAN UROLOGY | 2021年 / 79卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：889 / +
页数：3
相关论文
共 50 条
  • [41] STEREOTACTIC BODY RADIATION THERAPY AND ABIRATERONE ACETATE FOR PATIENTS AFFECTED BY OLIGOMETASTATIC CASTRATERESISTANT PROSTATE CANCER: A RANDOMIZED PHASE II TRIAL (ARTO-NCT03449719)
    Francolini, Giulio
    Allegra, Andrea Gaetano
    Caini, Saverio
    Di Cataldo, Vanessa
    Detti, Beatrice
    Alitto, Anna Rita
    Parisi, Silvana
    D'angelillo, Rolando Maria
    Bruni, Alessio
    Ingrosso, Gianluca
    Augugliaro, Matteo
    Lorenzetti, Victoria
    Orsatti, Carolina
    Caprara, Luisa
    Frosini, Giulio
    Burchini, Luca
    Lapini, Alberto
    Triggiani, Luca
    Desideri, Isacco
    Meattini, Icro
    Livi, Lorenzo
    ANTICANCER RESEARCH, 2023, 43 (10) : 4764 - 4765
  • [42] Randomized phase II trial in prostate cancer with hormone-sensitive OligometaSTatic relapse: Combining stereotactic ablative radiotherapy and durvalumab (POSTCARD GETUG P13): Study protocol
    Roge, Maximilien
    Pointreau, Yoann
    Sargos, Paul
    Meyer, Emmanuel
    Schick, Ulrike
    Hasbini, Ali
    Rio, Emmanuel
    Bera, Guillaume
    Ruffier, Amandine
    Quivrin, Magali
    Chasseray, Mathieu
    Latorzeff, Igor
    Martin, Etienne
    Guimas, Valentine
    Pommier, Pascal
    Leroy, Thomas
    Ronchin, Philippe
    Lepinoy, Alexis
    Grand, Audrey
    Cartier, Lysian
    Didas, Ossama
    Denis, Fabrice
    Libois, Vincent
    Blanc-Lapierre, Audrey
    Supiot, Stephane
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2023, 40
  • [43] Five-year outcomes of fractionated stereotactic body radiotherapy for oligometastatic prostate cancer from the TRANSFORM phase II trial
    See, Andrew W.
    Conway, Paul
    Frydenberg, Mark
    Haxhimolla, Hodo
    Costello, Anthony J.
    Moon, Daniel
    Ruljancich, Paul
    Grummet, Jeremy
    Pranavan, Ganes
    Peters, Justin
    Smyth, Lloyd M. L.
    Gwini, Stella M.
    Mckenzie, Dean P.
    Bowden, Patrick
    INTERNATIONAL JOURNAL OF CANCER, 2024, 155 (07) : 1248 - 1256
  • [44] Phase 2 randomized total eradication of metastatic lesions following definitive radiation to the prostate in de novo oligometastatic prostate cancer (TERPs) trial.
    Rana, Zaker Hamid
    Helie, Nicole
    Eggleston, Caitlin
    Baker, Kaysee
    Molitoris, Jason K.
    Ferris, Matthew J.
    Patel, Akshar
    Kwok, Young
    McAvoy, Sarah
    Kunaprayoon, Dan
    Hong, Jack J.
    Deek, Matthew
    Sutera, Philip
    Deek, Rebecca A.
    Bentzen, Soren
    Siddiqui, Minhaj
    Mannuel, Heather Dorothy
    Hussain, Arif
    Tran, Phuoc T.
    Mishra, Mark V.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [45] Outcomes of RAdium-223 and SABR vs. SABR for oligomEtastatic prostate caNcerS - The RAVENS Phase II Randomized Trial
    Tran, P. T.
    Sherry, A. D.
    Bazyar, S.
    Wang, J.
    Sutera, P.
    Radwan, N.
    Phillips, R.
    Deek, M. P.
    Lu, J.
    Dipasquale, S.
    Devine, C., Jr.
    DeWeese, T. L.
    Song, D.
    Wang, H.
    Abramowitz, M. C.
    Desai, N. B.
    Berlin, A.
    Stish, B. J.
    Tang, C.
    Kiess, A. P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : S7 - S7
  • [46] Androgen suppression and radiation vs radiation alone for prostate cancer - A randomized trial
    D'Amico, Anthony V.
    Chen, Ming-Hui
    Renshaw, Andrew A.
    Loffredo, Marian
    Kantoff, Philip W.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 299 (03): : 289 - 295
  • [47] Stereotactic ablative radiotherapy for comprehensive treatment of oligometastatic tumors (SABR-COMET): Study protocol for a randomized phase II trial
    Palma, David A.
    Haasbeek, Cornelis J. A.
    Rodrigues, George B.
    Dahele, Max
    Lock, Michael
    Yaremko, Brian
    Olson, Robert
    Liu, Mitchell
    Panarotto, Jason
    Griffioen, Gwendolyn H. M. J.
    Gaede, Stewart
    Slotman, Ben
    Senan, Suresh
    BMC CANCER, 2012, 12
  • [48] Phase III randomized trial of stereotactic ablative radiotherapy (SAbR) for oligometastatic advanced renal carcinoma (EA8211-SOAR).
    Cole, Suzanne
    Kim, Se Eun
    Wentland, Andrew
    Lin, Mu-Han
    Kapur, Payal
    Wulff-Burchfield, Elizabeth Marie
    Shevrin, Daniel
    Gurley, Tami
    Lin, John C.
    Wagner, Lynne I.
    McKay, Rana R.
    Brugarolas, James
    Qin, Qian
    Gunter, Tyler
    Kyriakopoulos, Christos
    Harichand-Herdt, Seema
    Sykes, Glenn
    Haas, Naomi Balzer
    Carducci, Michael A.
    Hannan, Raquibul
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL) : TPS615 - TPS615
  • [49] Phase III randomized trial of stereotactic ablative radiotherapy (SAbR) for oligometastatic advanced renal carcinoma (EA8211-SOAR).
    Kim, Se Eun
    Cole, Suzanne
    Wulff-Burchfield, Elizabeth Marie
    Wentland, Andrew
    Hannan, Mu-Han
    Kapur, Payal
    Shevrin, Daniel
    Gurley, Tami
    Lin, John Kent
    Brugarolas, James
    Timmerman, Robert D.
    Mckay, Rana R.
    Wagner, Lynne I.
    Haas, Naomi B.
    Carducci, Michael Anthony
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : TPS489 - TPS489
  • [50] Stereotactic ablative radiotherapy for comprehensive treatment of oligometastatic tumors (SABR-COMET): Study protocol for a randomized phase II trial
    David A Palma
    Cornelis J A Haasbeek
    George B Rodrigues
    Max Dahele
    Michael Lock
    Brian Yaremko
    Robert Olson
    Mitchell Liu
    Jason Panarotto
    GwendolynHMJ Griffioen
    Stewart Gaede
    Ben Slotman
    Suresh Senan
    BMC Cancer, 12
12345